biotech equivalent to microsoft, page-3

nice one, Sharesontoast. indeed very interesting & exciting times ahead.

here i have some key points from nick woolf's interview (Dec 2010):
- looking for 3rd partnership. CHECKED! pfizer came to the party :)

- next step with roche

- ongoing negotiations with the industry's top 10 (no kidding, big brother is watching!)

- confident at least 2-3 new deals in coming 12 months

- hoping next partnership comes from the US. is he talking about johnson & johnson?? from PYC web,.."if successful the relevant Phylomer? compounds will then be licensed to and developed exclusively by JJR. Phylogica will receive both upfront fees and milestone payments under the terms of agreement." (http://www.phylogica.com/display/index/current-partners)

value for PYC?? leave that to the market :) just a note of confidence, PYCO (ex 15c, 31/8/2011) is already trading at a premium (current price 0.016) valuing PYC @ 17c come august :) :)